Kaposi’s sarcoma-associated herpesvirus ubiquitin ligases downregulate cell surface expression of l-selectin
Kaposi’s sarcoma-associated herpesvirus ubiquitin ligases downregulate cell surface expression of l-selectin
复制标题
卡波西肉瘤相关疱疹病毒泛素连接酶下调细胞表面 L-选择素的表达
DOI:
10.1099/jgv.0.001678
复制
发表时间:
2021
影响因子:
3.8
通讯作者:
Kanamoto Taisei
中科院分区:
文献类型:
--
作者:
Kajikawa Mizuho;Imaizumi Nanae;Machii Shiho;Nakamura Tomoka;Harigane Nana;Kimura Minako;Miyano Kei;Ishido Satoshi;Kanamoto Taisei
Kaposi’s sarcoma-associated herpesvirus (KSHV) is an oncogenic etiological factor for Kaposi’s sarcoma and primary effusion lymphoma in immunocompromised patients. KSHV utilizes two immune evasion E3 ubiquitin ligases, namely K3 and K5, to downregulate the expression of antigen-presenting molecules and ligands of natural killer (NK) cells in the host cells through an ubiquitin-dependent endocytic mechanism. This allows the infected cells to evade surveillance and elimination by cytotoxic lymphocytes and NK cells. The number of host cell molecular substrates reported for these ubiquitin ligases is limited. The identification of novel substrates for these ligases will aid in elucidating the mechanism underlying immune evasion of KSHV. This study demonstrated that K5 downregulated the cell surface expression ofl-selectin, a C-type lectin-like adhesion receptor expressed in the lymphocytes. Tryptophan residue located at the centre of the E2-binding site in the K5 RINGv domain was essential to downregulatel-selectin expression. Additionally, the lysine residues located at the cytoplasmic tail ofl-selectin were required for the K5-mediated downregulation ofl-selectin. K5 promoted the degradation ofl-selectin through polyubiquitination. These results suggest that K5 downregulatesl-selectin expression on the cell surface by promoting polyubiquitination and ubiquitin-dependent endocytosis, which indicated thatl-selectin is a novel substrate for K5. Additionally, K3 downregulatedl-selectin expression. The findings of this study will aid in the elucidation of a novel immune evasion mechanism in KSHV.